Kuppalli is an infectious diseases physician in Dallas. As the FIFA World Cup approaches, speculation on social media and cable news has already begun: Could Ebola spread at the tournament? The short ...

In this morning's Pharmalittle roundup, we're reading about a hepatitis B drug, CVS returns Lilly obesity drug to formularies ...

Meghana Keshavan covers biotech and contributes to The Readout newsletter. Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.

The FDA extended the decision deadline for an experimental breast cancer pill from AstraZeneca after an advisory panel ...

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer ...

Stanford Health Care started asking patients about new AI tools before they are implemented. Here's what patients are telling ...

Inside the longevity conference that brings together founders, investors, biohackers, and the generally death-averse to ...

Andrew covers the biopharma industry, scientific research, and public health across the continent. You can reach Andrew confidentially on Signal at drewqjoseph.71. Eli Lilly said Tuesday it would buy ...

Trump has willingly exposed an entire generation of children to Big Tobacco’s nicotine addiction,” writes Sen. Dick Durbin.

In this edition of AI Prognosis, Brittany Trang takes a look at patients' role in how Stanford Health Care adopts AI tools, ...

Then why are so many optimistic scientists now losing heart? Because the nation’s research enterprise is shrinking.

People in the food world didn’t know what to expect when the Trump administration appointed a little-known Florida attorney ...